A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1:

Arutselvan Natarajan1, Chirag B Patel1,2, Sindhuja Ramakrishnan1

  • 1Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, California.

Abstract

Insights

A novel small protein binder, 64Cu-FN3hPD-L1, effectively images human programmed death-1 ligand (hPD-L1) in tumors using PET. This tracer shows promise for identifying cancer patients eligible for immune checkpoint therapies.

Area of Science:

  • Biotechnology
  • Molecular Imaging
  • Oncology

Background:

  • Immune checkpoint blockade therapies, such as those targeting human programmed death-1 ligand (hPD-L1), have revolutionized cancer treatment.
  • Accurate identification of patients who will respond to these therapies is crucial for optimizing treatment outcomes.
  • Current imaging methods for hPD-L1 expression have limitations, necessitating the development of novel, high-affinity tracers.

Purpose of the Study:

  • To design and evaluate a small engineered protein binder, FN3hPD-L1, for targeting hPD-L1.
  • To assess the in vivo performance of the radiolabeled binder (64Cu-FN3hPD-L1) using Positron Emission Tomography (PET) imaging in mouse tumor models.
  • To evaluate the binder's utility for in situ imaging in human cancer specimens.

Main Methods:

  • Engineered a 12-kDa human fibronectin type-3 domain (FN3) scaffold to create the FN3hPD-L1 binder.
  • Assayed binder affinity using CT26 mouse colon carcinoma cells expressing hPD-L1 (CT26/hPD-L1).
  • Radiolabeled FN3hPD-L1 with Copper-64 (64Cu) and evaluated the resulting tracer (64Cu-FN3hPD-L1) for purity, specific activity, and immunoreactivity.
  • Conducted PET imaging in NSG mice bearing various tumors (hPD-L1-positive syngeneic, hPD-L1-negative xenografts, and hPD-L1-positive xenografts with blocking) and evaluated immunostaining in human cancer specimens.

Main Results:

  • FN3hPD-L1 demonstrated high affinity (1.4 ± 0.3 nmol/L) for hPD-L1.
  • The 64Cu-FN3hPD-L1 radiotracer exhibited high yield (>70%) and purity (>95%).
  • PET imaging revealed significant tumor uptake in mice with CT26/hPD-L1 tumors, with tumor-to-muscle ratios of 5.6 ± 0.9 at 1 hour and 13.1 ± 2.3 at 4 hours postinjection.
  • The binder successfully detected hPD-L1 expression in human tissues, correlating with validated antibody staining.

Conclusions:

  • The 64Cu-FN3hPD-L1 radiotracer is a novel, small, high-affinity binder suitable for imaging hPD-L1 in tumors.
  • The findings support the potential clinical translation of this binder for noninvasive identification of cancer patients who may benefit from immune checkpoint blockade therapies.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
570
Role of Proteins in the Human Body01:28

Role of Proteins in the Human Body

Proteins are the building block of life. They are also  the most abundant macromolecules with as many diverse roles in the body. They are part of many structural components that provide unique shapes and structures to animal cells, tissues, and organs. In addition, they also act as biological catalysts and carry out several anabolic and catabolic reactions. Notably, some proteins are chemical messengers and regulate many critical processes, such as metabolism, growth, and development. They...
6.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K
Emission Spectra02:39

Emission Spectra

When solids, liquids, or condensed gases are heated sufficiently, they radiate some of the excess energy as light. Photons produced in this manner have a range of energies, and thereby produce a continuous spectrum in which an unbroken series of wavelengths is present.
76.3K